VectivBio Holding AG

NASDAQ:VECT   3:59:53 PM EDT
8.75
-0.78 (-8.18%)
Products

Vectivbio Receives FDA Orphan Drug Designation For Apraglutide For Acute Graft-Versus-Host Disease

Published: 06/24/2021 11:45 GMT
VectivBio Holding AG (VECT) - Vectivbio Receives FDA Orphan Drug Designation for Apraglutide for Acute Graft-versus-host Disease.
Vectivbio Holding Ag - Plans to Initiate Phase 2 Trial Evaluating Apraglutide for Treatment of Agvhd in Q1 of 2022.